Business Segments · Other
North American Pharmaceutical — Other
McKesson North American Pharmaceutical — Other remained flat by 0.0% to -$250.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 80.0%, from -$1.25M to -$250.00K.
Analysis
StatementSegment
CategoryOther
SignalContext dependent
VolatilityModerate
First reportedQ2 2024
Last reportedQ1 2026
How to read this metric
Significant fluctuations in this category may signal underlying operational volatility or the presence of non-recurring accounting adjustments that require further investigation.
Detailed definition
Residual operational expenses or income items within the North American pharmaceutical segment that do not fit into prim...
Peer comparison
Similar to 'Other' line items in segment reporting across various industries, often used for immaterial operational noise.
Metric ID:
mck_segment_north_american_pharmaceutical_otherHistorical Data
2 years
| FY'25 | FY'26 | |
|---|---|---|
| Value | -$5.00M | -$1.00M |
| YoY Change | — | +80.0% |
Range-$5.00M – -$1.00M
Avg YoY Growth+80.0%
Median YoY Growth+80.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is McKesson's north american pharmaceutical — other?
- McKesson (MCK) reported north american pharmaceutical — other of -$250.00K in Q1 2026.
- How has McKesson's north american pharmaceutical — other changed year-over-year?
- McKesson's north american pharmaceutical — other increased by 80.0% year-over-year, from -$1.25M to -$250.00K.
- What does north american pharmaceutical — other mean?
- Miscellaneous operational income or expense items specific to the North American pharmaceutical segment.